Vaxart Inc (VXRT)
6.94
-0.26 -3.61%
NASDAQ
Oct 15, 16:00
6.96
+0.02 +0.29%
After-Hours: 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 1.239M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.48 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -54.07M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -14.39K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 869.38M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 635.59 |
| PE Ratio | -- |
| Price to Book Value | 4.352 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -15.36M |
| Return on Equity | Upgrade |
View All VXRT News
News
-
WireHeadlineTime (ET)
-
Yahoo10/16 11:30
-
Yahoo10/13 18:54
-
Yahoo10/10 06:00
-
MT Newswires10/08 16:29
-
Yahoo10/08 09:57
-
PR Newswire10/08 08:30
-
SA Breaking News10/08 08:13
-
Yahoo10/08 07:57
-
Yahoo10/08 07:34
-
Yahoo10/08 04:45
-
Yahoo10/07 19:16
-
MT Newswires10/07 17:37
-
Yahoo10/07 16:57
-
MT Newswires10/07 16:32
-
Yahoo10/07 16:13
-
Yahoo10/07 10:00
-
Yahoo10/07 07:29
-
Yahoo10/06 14:20
-
MT Newswires10/06 08:30
-
Yahoo10/06 08:00
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/12/2021 | Earnings Results | Q3 2021 Earnings Results |
| 08/05/2021 | Earnings Results | Q2 2021 Earnings Results |
| 06/16/2021 09:30 EST | AGM | 2021 Annual General Meeting |
| 05/06/2021 | Earnings Results | Q1 2021 Earnings Results |
| 02/25/2021 | Earnings Results | Q4 2020 Earnings Results |
| 11/12/2020 | Earnings Results | Q3 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
- URL: https://www.vaxart.com
- Investor Relations URL: https://investors.vaxart.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Nov. 12, 2021
- Last Earnings Release: Aug. 05, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Nov. 09, 2012
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 6.94 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| FNDRX | FRC Founders Index | 0.32% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VXRT Tweets Stocktwits
Advertisement
